In this work, we found that MLA, a selective α7nAChR inhibitor, noticeably inhibited the protective effect of ANI/NEO on DSS-induced colitis and intestinal proinflammatory cytokines indicating that α7nAChR mediates the therapeutic effect of ANI/NEO. Here, CHRNA7 is linked to colitis.